DNM1L and diabetes mellitus: To address whether mtDYN plays a causal role in regulating cellular IR and serves as a potential therapeutic target, we have bidirectionally manipulated the expression of dynamic proteins, including MFN1, MFN2, DRP1, and FIS1 in cybrid cell harboring diabetes-susceptible haplogroup B4.